Rankings
▼
Calendar
EOLS FY 2019 Earnings — Evolus, Inc. Revenue & Financial Results | Market Cap Arena
EOLS
Evolus, Inc.
$338M
FY 2019 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$35M
Gross Profit
$27M
77.1% margin
Operating Income
-$99M
-283.3% margin
Net Income
-$90M
-257.8% margin
EPS (Diluted)
$-3.19
Cash Flow
Operating Cash Flow
-$93M
Free Cash Flow
-$98M
Stock-Based Comp.
$10M
Balance Sheet
Total Assets
$240M
Total Liabilities
$161M
Stockholders' Equity
$79M
Cash & Equivalents
$110M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$35M
$0
—
Gross Profit
$27M
-$9,000
+299111.1%
Operating Income
-$99M
-$46M
-114.4%
Net Income
-$90M
-$47M
-92.1%
← Q4 2018
All Quarters
Q1 2019 →